Print

Link Technologies Ltd Release: Introducing the New Link+ Range at OTS  
10/3/2013 9:51:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BELLSHILL, SCOTLAND, 3 October 2013: Link Technologies Ltd, a specialist manufacturer of oligonucleotide reagents, is launching its high-end Link+ range at the 9th Annual Meeting of the Oligonucleotide Therapeutic Society (OTS), which takes place in Naples, Italy, from 6-8 October. Manufactured to the highest available industry specification, Link+ will offer customers a collection of premium phosphoramidites to bring new standards to the modifier reagent market. In addition to the supply of high purity products, Link+ customers will benefit from a bespoke service from order to delivery, which includes a detailed impurity profile for thorough quality assurance - vital for oligos with diagnostic and therapeutic applications. Providing support and managed supply throughout the entirety of project life-cycles, Link Technologies has scaled manufacturing capacity for the provision of gram to kilo-based quantities for research and commercial-scale applications.

Ideal for CMOs and manufacturers working to GMP and other stringent quality specifications (eg ISO 13485), Link+ now ensures that modified reagents meet the top-level purity standards previously only available for the principal DNA bases. As standard, the minimum specifications of Link+ reagents are the highest available on the market, however these can be further modified to suit customers’ own QC requirements. For greater assurance, the detailed analytical data provided as part of the Link+ service, including LCMS, NMR and HPLC, can even be supplied prior to shipping to ensure the products meet exact specifications before delivery.

Certified to ISO 9001:2008, Link Technologies has developed the Link+ service to offer flexibility, guaranteeing an enhanced and tailor-made customer experience. Dr Catherine McKeen, Technical Manager at Link Technologies, explains: “Working with several key clients has helped us develop this service, and indeed some already benefit from our manufacture of tailored, highly specified products. We are now rolling this out under the Link+ brand, to distinguish the service from our off-the-shelf catalogue products. The Link+ reagent range will therefore grow in line with customer requirements, providing the added level of assurance for those working to GMP, especially in diagnostic and therapeutic applications.”

For more information please visit us during our poster presentation at OTS, visit the Link Technologies website at www.linktech.co.uk, or follow us on Twitter: @linktechdna.

About Link Technologies Ltd

Link Technologies Ltd is a leading kilo-scale supplier of speciality reagents for oligonucleotide synthesis and modification, all to the ISO 9001:2008 quality certification. The company’s main markets are university and commercial research departments, plus, increasingly, larger Contract Manufacturing Organisations (CMOs) in the biotech sector.

Link has also forged successful links to academia working closely with many UK universities. In tandem with internal research and development, the Company has an excellent record in bringing in-licence products to market with various worldwide commercial partners.

For further information see: www.linktech.co.uk.

Help employers find you! Check out all the jobs and post your resume.

//-->